Respiratory and systemic infections in children with severe aplastic anemia on immunosuppressive therapy

Area of Science:

• Pediatric Hematology
• Infectious Diseases
• Immunosuppression Therapy

Background:

• Severe acquired aplastic anemia (SAA) is a rare but serious condition requiring immunosuppressive therapy (IST).
• Patients undergoing IST are at increased risk for systemic and respiratory infections.
• Identifying infection risks is crucial for improving outcomes in pediatric SAA patients.

Purpose of the Study:

• To investigate the incidence and types of infections in children with SAA receiving IST.
• To evaluate the impact of different immunosuppressive agents and G-CSF on infection rates.
• To identify key risk factors and causes of mortality in this patient population.

Main Methods:

• Retrospective analysis of a cohort of 123 children with SAA on IST.
• Recording and categorizing infection episodes, including pneumonia and sepsis.
• Comparing infection rates between patients treated with horse vs. rabbit antithymocyte globulin (h-ATG vs. r-ATG) and with or without G-CSF.

Main Results:

• 62.6% of patients experienced 101 infection episodes; pneumonia occurred in 16.8%.
• Mortality was 18.7% (23/123), with sepsis and pneumonia complications being leading causes.
• G-CSF treatment was associated with a 36% relative risk reduction in infectious complications (RR 0.64; p < 0.0001).

Conclusions:

• Respiratory and disseminated infections pose a significant threat and are primary causes of death in pediatric SAA patients.
• Active surveillance for opportunistic infections is essential.
• G-CSF may be a valuable adjunct therapy for reducing infection risk in SAA patients on IST.